US Stock MarketDetailed Quotes

SEPN Septerna

Watchlist
  • 25.510
  • +0.320+1.27%
Trading Dec 6 11:20 ET
1.13BMarket Cap-57069P/E (TTM)

About Septerna Company

Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. Its pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. The company was founded by Robert Joseph Lefkowitz, Arthur Christopoulos, Patrick Sexton, and Jeffrey T. Finer in December 2019 and is headquartered in South San Francisco, CA.

Company Profile

SymbolSEPN
Company NameSepterna
Listing DateOct 25, 2024
Issue Price18.00
Founded2019
CEODr. Jeffrey T. Finer, M.D.,PhD
MarketNASDAQ
Employees68
Fiscal Year Ends12-31
Address250 East Grand Avenue
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-338-3533

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jeffrey T. Finer, M.D.,PhD
  • Chief Executive Officer, President and Director
  • 2.14M
  • Dr. Jae B. Kim, M.D.
  • Chief Medical Officer
  • --
  • Samira Shaikhly
  • Chief People Officer
  • 742.54K
  • Liz Bhatt
  • Chief Operating Officer
  • 883.70K
  • Ran Xiao, C.F.A.
  • Principal Accounting Officer, Interim Chief Financial Officer and Vice President of Finance and Business Operations
  • --
  • Dr. Uwe Klein, PhD
  • Senior Vice President, Biological Sciences
  • 578.53K
  • Dr. Daniel Long, D.Phil.
  • Senior Vice President, Drug Discovery
  • 646.74K
  • Dr. Jeffrey K. Tong, PhD
  • Chairman of the Board
  • --
  • Dr. Alan Ezekowitz, D.Phil.,MB.Ch.B.
  • Director
  • --
  • Dr. Bernard Coulie, M.B.A.,M.D.,PhD
  • Independent Director
  • 100.42K
  • Shalini Sharp
  • Independent Director
  • --
  • Abraham Bassan
  • Independent Director
  • --
  • Dr. Jake Sin, PhD
  • Independent Director
  • --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.